NIPPON ZENYAKU KOGYO CO LTD has a total of 45 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MULTIMMUNE GMBH, CELTRIX PHARMA and TR ASSOCIATES L L C.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 11 | |
#2 | United States | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 9 | |
#4 | Australia | 5 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Republic of Korea | 3 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Basic materials chemistry | |
#6 | Environmental technology | |
#7 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Iwabuchi Shigehiro | 18 |
#2 | Tsukui Toshihiro | 17 |
#3 | Suzuta Yasuyuki | 13 |
#4 | Miyake Masashi | 11 |
#5 | Saze Kohichi | 6 |
#6 | Mizuno Takuya | 5 |
#7 | Tsujimoto Hajime | 5 |
#8 | Matsunaga Tomio | 4 |
#9 | Suzuki Rieko | 4 |
#10 | Kato Masahiro | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021066134A1 | Monoclonal antibody or antibody fragment against canine cd20 | |
WO2019003358A1 | Liquid administration tool | |
US2018319879A1 | Anti-canine tarc antibody used for treatment and diagnosis of canine atopic dermatitis | |
EP3168236A1 | Anti-canine pd-1 antibody or anti-canine pd-l1 antibody | |
WO2015133439A1 | Pullulan gel, method for producing same, and use of same | |
CN104395337A | Ige peptide vaccine | |
KR20120080561A | Novel mite allergen | |
EP2221062A1 | Novel adjuvant | |
US2011091490A1 | Novel vaccine for dog | |
US2009005448A1 | Injection for Mastitis | |
AU2005231004A1 | Novel mite allergen | |
CA2413754A1 | Canine hepatocyte growth factor | |
CA2410762A1 | Feline hepatocyte growth factor |